55 studies found for:    "Coccidioidomycosis"
Show Display Options
Rank Status Study
1 Not yet recruiting Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention: Drug: Sertraline
2 Completed
Has Results
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
Condition: Coccidioidomycosis
Interventions: Drug: Posaconazole;   Drug: Fluconazole
3 Completed A Multi-center Study of Spherule-Derived Coccidioidin
Condition: Coccidioidomycosis
Intervention: Biological: Spherule-derived coccidioidin
4 Recruiting Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention:
5 Completed Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Conditions: Coccidioidomycosis;   Rheumatoid Arthritis
Intervention:
6 Recruiting Early Fluconazole Treatment for Coccidiodomycosis Pneumonia
Condition: Coccidioidomycosis
Interventions: Drug: Fluconazole;   Other: Placebo
7 Completed Rift Valley Fever in Kenya
Condition: Rift Valley Fever
Intervention:
8 Completed Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
Condition: Rift Valley Fever
Intervention: Biological: RVF MP-12
9 Terminated Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
Condition: Coccidioidomycosis
Intervention: Drug: nikkomycin Z
10 Completed Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
11 Enrolling by invitation Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
12 Completed A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
Conditions: Mycoses;   HIV Infections;   Coccidioidomycosis
Intervention: Drug: Fluconazole
13 Completed Antiretroviral Drug Interaction Study in Volunteers With HIV
Conditions: HIV;   PCP;   Toxoplasmosis
Interventions: Drug: Atovaquone 750 mg twice daily;   Drug: Atovaquone 1500 mg twice daily
14 Completed
Has Results
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
Condition: Malaria
Interventions: Biological: RTS,S/AS02D;   Biological: Engerix-B®;   Biological: TETRActHib™
15 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
16 Completed Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children
Condition: Plasmodium Falciparum Malaria
Intervention: Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
17 Active, not recruiting Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia
Conditions: Toxoplasmosis;   Schizophrenia
Interventions: Drug: Sodium Valproate treatment;   Drug: Placebo
18 Completed Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
Conditions: Meningitis;   HIV Infections
Intervention: Drug: Fluconazole
19 Recruiting Lyon Cohort of Maternal and Congenital Toxoplasma Infections
Condition: Toxoplasmosis, Congenital
Intervention:
20 Unknown  Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.